R&D Briefing 55 The impact of the changing regulatory environment on the approval of new medicines across six major authorities 2004-2013
2015 Activities Schedule
Survey responses regarding regulatory and HTA agency attitudes toward adaptive licensing. From Liberti et al, WHO CCPPR Winter Meeting, January 2015.
Slide of the Month Archive •>
© 2015 CIRS (Centre for Innovation in Regulatory Science)